Racial disparity in all-cause mortality among hepatitis C virus-infected individuals in a general US population, NHANES III

Journal of Viral Hepatitis

Volumn 24, Issue 5, 2017, Pages 380-388

  Emmanuel, B ^a   Shardell, M D ^b   Tracy, L ^a,c   Kottilil, S ^a   El Kamary, S S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

hepatitis C virus; Mexican Americans; mortality; racial disparity

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHRONIC HEPATITIS C; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICAN AMERICAN; MIDDLE AGED; MORTALITY RATE; RACE DIFFERENCE; UNITED STATES; ADOLESCENT; AGE; AGED; ETHNIC GROUP; MORTALITY; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MORTALITY; SEX FACTORS; UNITED STATES; YOUNG ADULT;

EID: 85006162240     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12656     Document Type: Article

References (29)

1. Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis. 2012;55(suppl 1):S10–S15.
2. Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014;160:293–300.
3. Centers for Disease Control and Prevention. Viral Hepatitis Surveillance United States, 2014 [Internet]. 2014. Available from: http://www.cdc.gov/hepatitis/statistics/2014surveillance/index.htm. Accessed June 14, 2016.
4. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3:47–52.
5. Nelson KE. The impact of chronic hepatitis C virus infection on mortality. J Infect Dis. 2012;206:461–463.
6. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010;138:513–521.
7. Kabiri M, Jazwinski AB, Roberts MS, Schaefer AJ, Chhatwal J. The changing burden of hepatitis C virus infection in the United States: model-based predictionsthe changing burden of hepatitis C virus infection. Ann Intern Med. 2014;161:170–180.
8. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012 Feb 21;156:271–278.
9. Kohli A, Shaffer A, Sherman A, Kottilil S. Treatment of hepatitis C: a systematic review. JAMA. 2014;312:631–640.
10. Innes HA, McDonald SA, Dillon JF, et al. Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes. Hepatology. 2015;62:355–364.
11. Dieperink E, Pocha C, Thuras P, Knott A, Colton S, Ho SB. All-cause mortality and liver-related outcomes following successful antiviral treatment for chronic hepatitis C. Dig Dis Sci. 2014;59:872–880.
12. Yehia BR, Schranz AJ, Umscheid CA, Lo Re V. The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS ONE. 2014;9:e101554.
13. Holmberg SD, Spradling PR, Moorman AC, Denniston MM. Hepatitis C in the United States. N Engl J Med. 2013;368:1859–1861.
14. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556–562.
15. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705–714.
16. El-Kamary SS, Jhaveri R, Shardell MD. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population. Clin Infect Dis. 2011;53:150–157.
17. van der Meer AJ, Veldt BJ, Feld JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis c and advanced hepatic fibrosis. JAMA. 2012;308:2584–2593.
18. Dieperink E, Pocha C, Thuras P, Knott A, Colton S, Ho SB. All-cause mortality and liver-related outcomes following successful antiviral treatment for chronic hepatitis C. Dig Dis Sci. 2014;59:872–880.
19. Tohme RA, Xing J, Liao Y, Holmberg SD. Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009–2010. Am J Public Health. 2013;103:112–119.
20. National Center for Health Statistics, Centers C for DC and PWS. National Health and Nutrition Examination Survey [Internet]. [cited October 1, 2015]. Available from: http://www.cdc.gov/nchs/nhanes/nh3data.htm. Accessed October 23, 2015.
21. Ezzati TM, Massey JT, Waksberg J, Chu A, Maurer KR. Sample design: Third National Health and Nutrition Examination Survey. Vital Health Stat 2. 1992;113:1–35.
22. Gunter EW, Lewis BG, Koncikowski SM. Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 [Internet]. Atlanta, GA: National Center for Environmental Health, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services; 1996. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/nchs/manuals/labman.pdf. Accessed October 23, 2015.
23. National Center for Health Statistics C for DC and PWS. Office of Analysis and Epidemiology, Public-use Linked Mortality File, 2015 [Internet]. Hyattsville, Maryland; [cited August 1, 2015]. Available from: http://www.cdc.gov/nchs/data_access/data_linkage/mortality.htm. Accessed October 23, 2015.
24. R Development Core Team. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2015. Available from: http://www.R-project.org. Accessed October 23, 2015.
25. Mooneshinghe R, Chang M, Truman BI. Health Insurance Coverage — United States, 2008 and 2010. MMWR [Internet]. 2013 Nov 22 [cited May 17, 2016];62(3). Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/su6203a10.htm?s_cid=su6203a10_w#x2014; United States, 2008 and 2010. Accessed May 17, 2016.
26. Haile RW, John EM, Levine AJ, et al. A review of cancer in U.S. Hispanic populations. Cancer Prev Res (Phila Pa). 2012;5:150–163.
27. Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol. 2014;109:542–553.
28. Setiawan VW, Wei PC, Hernandez BY, et al. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: the multiethnic cohort. Cancer. 2016;122:1444–1452.
29. El-Serag HB, Kramer J, Duan Z, Kanwal F. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans. Am J Gastroenterol. 2014;109:1427–1435.